Media

Dish of the day
No Joiners today
Off the menu
No leavers today

Q4 2023. Hybridan & Poolbeg Pharma discussion on AI Programmes

Jeremy Skillington & Emily Liu discuss Poolbeg Pharma's exciting AI Programmes

2022 Q3 Interview

Our CEO, Claire Noyce, Joins Nucleus195 To Discuss All Things Hybridan

Head Of Corporate Broking, Niall Pearson And Corporate Broking Associate, Sacha Morris Join UK Investor Magazine On Their Latest Podcast

2022 Q2 Podcast

Head Of Research, Derren Nathan And Head Of Corporate Broking, Niall Pearson Join UK Investor Magazine On Their Latest Podcast

2022 Q1 Interview

Derren Nathan, Head Of Research At Hybridan LLP Sits Down With Master Investor To Discuss Their Latest Research On 'The Evolution Of Fintech'

Derren Nathan, Head Of Research From Hybridan LLP Talks To Proactive London About Their Latest Research On 'The Evolution Of Fintech'.

2021 Q4 Interview

Derren Nathan, Director And Head Of Research At Hybridan LLP Joins Master Investor's Sarah Lowther To Discuss The Rapidly Developing Technology And Industries Surrounding The Evolution Of The Hydrogen Economy.

Hybridan's CEO, Claire Noyce, Joins The Small Cap Network To Discuss The Opportunities And Challenges Of Becoming A Public Company

2021 Q3 Interview

Hybridan's Head Of Corporate Broking, Niall Pearson, Sits Down With DirectorsTalk To Provide A Brief Overview Of Symphony Environmental, How They've Adapted From Covid And Some Background Around Their Pivotal Deal With Meditech.

2021 Q2 Podcast

Hybridan CEO, Claire Louise Noyce, Joins Beyond Governance's Podcast To Discuss DEI In UK Capital Markets.

Hybridan Head Of Research, Derren Nathan Featured On The The Quoted Companies Alliance Catching The Analysts' Eye Programme. Derren Shares His Thoughts On What Companies Can Do To Stand Out From The Crowd:

Hybridan CEO, Claire Louise Noyce Chairs A Master Investor Sponsored
Round Table Webinar, Reviewing Small Caps In 2021.

2021 Q1 Articles

Derren Nathan Of Hybridan Takes A Detailed Look At Sareum Holdings Who Is Investigating Small Molecule In The Treatment Of Auto-Immune Disease, Cancer, And With The Award Of A Recent NIHR Grant, Severe Phase Covid-19.

STAY INFORMED

Our daily digest of news from UK listed Small and Mid-caps straight to your Inbox.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram